H. L. Fillmore

Targeting G protein-coupled receptor-17 (GPR17) upregulation in paediatric diffuse midbrain gliomas leads to altered phenotype and susceptibility to therapies.

This study shows that targeting GPR17 in pDMG cells alters their phenotype and increases sensitivity to therapies.

CD15 and CD15s expression is associated with G1 phase of the cell cycle in glioma cell lines

This study shows CD15 and CD15s are more expressed in G1 phase of glioma cells compared to non-synchronized cells.